VATSUltrasound-Guided Erector Spinae Plane Block for Postoperative Pain Management in Obese Patients After Video-Assisted Thoracoscopy
This study aims to evaluate the effectiveness of Ultrasound-Guided Erector Spinae Plane Block for managing postoperative pain in obese patients after Video-Assisted Thoracoscopy, specifically focusing on the time to first rescue analgesia during the first 24 hours post-operation.
Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)
Treatment Study
Summary
Study start date: July 8, 2025
Actual date on which the first participant was enrolled.This clinical trial aims to compare the safety and effectiveness of two different methods for managing pain after a type of lung surgery called video-assisted thoracoscopy in obese patients. The two methods are Ultrasound-Guided Erector Spinae Plane Block (ESPB) and intravenous nalbuphine. The ESPB is a less invasive regional anesthesia technique that involves injecting a local anesthetic into a specific area of the back, while nalbuphine is a pain relief medication given through a vein. The study is important because adequate pain management after surgery can help prevent respiratory complications and improve recovery. The trial will include 102 patients who are planned for video-assisted thoracoscopy and meet certain criteria. During the trial, patients will be randomly assigned to either the ESPB group or the nalbuphine group. Patients in the ESPB group will receive the local anesthetic injection after the surgery, while patients in the nalbuphine group will receive the pain relief medication through a vein. The study will measure the total amount of nalbuphine used in the first 24 hours after surgery, the time until the first dose of rescue pain medication is needed, and the intensity of pain at rest and during movement. The study will also evaluate side effects related to the use of opioids, such as sedation, itching, and respiratory depression, as well as patient satisfaction with their pain management.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.102 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 60 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location